Company: AEMD
Filing Date: 2025-04-08
Form Type: PRE 14A
Source: 0001683168-25-002332
Chunk: 0

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-08
Form: PRE 14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No. __)</div>

Filed by the Registrant ☒

Filed by a party other than the Registrant ☐

Check the appropriate box:

| ☒                                                                        | Preliminary Proxy Statement                                                     |
| ☐                                                                        | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐                                                                        | Definitive Proxy Statement                                                      |
| ☐                                                                        | Definitive Additional Materials                                                 |
| ☐                                                                        | Soliciting Material under § 240.14a-12                                          |
| AETHLON MEDICAL, INC.                                                    |                                                                                 |
| (Name of Registrant as Specified In Its Charter)                         |                                                                                 |
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |                                                                                 |

Payment of Filing Fee (Check all boxes that apply):

☒ No
fee required

☐ Fee
paid previously with preliminary materials

☐ Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

11555 Sorrento Valley Road

Suite 203

San Diego, CA 92121

To Our Stockholders:

You are cordially invited to attend our Special
Meeting of Stockholders (the “Special Meeting”) on Tuesday, May 13, 2025 at 8:00 a.m., Pacific Time. To facilitate stockholder
participation in the Special Meeting and to provide a consistent and convenient experience to all stockholders regardless of location,
the Special Meeting will be held in a virtual meeting format only, via live webcast on the Internet at _____, with no physical in-person
meeting. Stockholders attending the virtual meeting will be afforded the same rights and opportunities to participate as they would at
an in-person meeting. We encourage you to attend online and participate in the Special Meeting, where you will be able to listen to the
meeting live, submit questions and vote. We recommend that you log in a few minutes before the Special Meeting on May 13, 2025 to ensure
you are logged in when the Special Meeting starts.

We have elected to provide access to our proxy
materials